LP
WVE icon

LMR Partners’s Wave Life Sciences WVE Stock Holding History

LMR Partners’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100,000
Closed -$1.7M – 1919
2025
Q4 		$1.7M Buy
+100,000
New +$1.02M ﹤0.01% 854
2023
Q2 		– Sell
-39,459
Closed -$171K – 1141
2023
Q1 		$171K Buy
+39,459
New +$181K ﹤0.01% 878
2022
Q4 		– Sell
-15,789
Closed -$57K – 1293
2022
Q3 		$57K Hold
15,789
– – ﹤0.01% 1086
2022
Q2 		$51K Buy
+15,789
New +$30.4K ﹤0.01% 1159

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
GP
GSK plc London $602M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

LMR Partners's WVE Position: Q1 2026 in Review

LMR Partners sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 100,000 shares — an estimated $1.7M sold.

LMR Partners first reported a position in WVE in Q2 2022 and held it in 4 quarters. The position peaked at $1.7M in Q4 2025. 232 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • LMR Partners reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • LMR Partners sold 100,000 Wave Life Sciences shares in Q1 2026, an estimated $1.7M.
  • LMR Partners first reported a position in Wave Life Sciences in Q2 2022 and held it in 4 quarters.
  • LMR Partners's Wave Life Sciences position peaked at $1.7M in Q4 2025.
  • 232 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.